Preanalytical standardization of amino acid and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry

被引:43
作者
Brauer, Romy [1 ]
Leichtle, Alexander Benedikt [1 ]
Fiedler, Georg Martin [1 ]
Thiery, Joachim [1 ]
Ceglarek, Uta [1 ]
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany
关键词
Metabolite profiling; Preanalytical standardization; Amino acids; Acylcarnitines; Dried blood; METABOLOMICS; PLASMA; URINE; SPOTS; PERSPECTIVE; VALIDATION; DIAGNOSIS; PHASE;
D O I
10.1007/s11306-010-0256-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quantitative metabolite profiling in biological samples has the potential to reflect physiological status and to identify disease associated disturbances in metabolic networks. However, this approach is hampered by a wide range of preanalytical variables. Hence, the aim of our study was to develop a standardized preanalytical protocol for metabolite profiling of amino acids and acylcarnitines in human blood. Amino acids and acylcarnitines were simultaneous analyzed after butylation of 3 mu L dried blood or 10 mu L whole blood, serum and anticoagulated plasma using electrospray tandem-mass spectrometry. The influence of exogenous and endogenous preanalytical variables was investigated in healthy volunteers. Different sampling materials and anticoagulants for blood taking were investigated. Concentrations of long-chain acylcarnitines were 5-fold higher in EDTA-whole blood or dried whole blood compared to serum and anticoagulated plasma. Significant differences in amino acid concentrations were found for capillary versus venous blood taking. Fasting for 8 h before specimen collection minimized the nutritional influence. Physical activity significantly alters amino acid and short chain acylcarnitine concentrations. As a result of our preanalytical investigation we developed a pre-treatment protocol based on EDTA whole blood dried on filter paper to reduce the preanalytical variability and facilitate reproducible quantitative metabolite profiling in clinical trials.
引用
收藏
页码:344 / 352
页数:9
相关论文
共 35 条
[1]   Newborn screening: Current status [J].
Arn, Pamela H. .
HEALTH AFFAIRS, 2007, 26 (02) :559-566
[2]  
Blau N., 2003, Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, DOI 10.1007/978-3-642-55878-8
[3]  
Bremer HJ., 1981, Disturbances of Amino Acid Metabolism
[4]   Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis [J].
Bruce, Stephen J. ;
Jonsson, Par ;
Antti, Henrik ;
Cloarec, Olivier ;
Trygg, Johan ;
Marklund, Stefan L. ;
Moritz, Thomas .
ANALYTICAL BIOCHEMISTRY, 2008, 372 (02) :237-249
[5]   Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry:: Sensitive newborn screening for phenylketonuria [J].
Ceglarek, U ;
Müller, P ;
Stach, B ;
Bührdel, P ;
Thiery, J ;
Kiess, W .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (07) :693-697
[6]   Challenges and developments in tandem mass spectrometry based clinical metabolomics [J].
Ceglarek, Uta ;
Leichtle, Alexander ;
Bruegel, Mathias ;
Kortz, Linda ;
Brauer, Romy ;
Bresler, Kristin ;
Thiery, Joachim ;
Fiedler, Georg Martin .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) :266-271
[7]   A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing [J].
Chace, DH ;
Kalas, TA .
CLINICAL BIOCHEMISTRY, 2005, 38 (04) :296-309
[8]  
Chace DH, 1997, CLIN CHEM, V43, P2106
[9]   Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry [J].
De Jesus, Victor R. ;
Chace, Donald H. ;
Lim, Timothy H. ;
Mei, Joanne V. ;
Hannon, W. Harry .
CLINICA CHIMICA ACTA, 2010, 411 (9-10) :684-689
[10]   Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes [J].
Dunn, Warwick B. .
PHYSICAL BIOLOGY, 2008, 5 (01)